Male Scientist

Our Technology

Beyond its remote-controlled cancer drug delivery platform and COVID-19 nanoparticle treatment, Global Cancer Technology is commercializing its technologies through wholly owned subsidiaries.

 

Click below to learn more about our subsidiaries.

GCT-1.png

MCW Pharmaceuticals

UCN-01 for sensitizing tumors

GCT-2.png

NanoMed Tracking

Nano quantum dots for tracking medical instruments 

GCT-3.png

HIFU+

‘Boiling histotripsy’ to treat cancer

GCT-1.png

NanoDrug Transport

Nanotechnology treatment for
COVID-19 and cancer

AdobeStock_226212386.jpeg